DE3770355D1 - Injektionsloesung von cephalosporinen. - Google Patents

Injektionsloesung von cephalosporinen.

Info

Publication number
DE3770355D1
DE3770355D1 DE8787109995T DE3770355T DE3770355D1 DE 3770355 D1 DE3770355 D1 DE 3770355D1 DE 8787109995 T DE8787109995 T DE 8787109995T DE 3770355 T DE3770355 T DE 3770355T DE 3770355 D1 DE3770355 D1 DE 3770355D1
Authority
DE
Germany
Prior art keywords
injection solution
cephalosporines
quinuclindinio
methoxyiminoacetamido
cephem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787109995T
Other languages
English (en)
Inventor
Yasuo Ishibashi
Muneaki Matsuda
Kazuhide Ashizawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE3770355D1 publication Critical patent/DE3770355D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE8787109995T 1986-07-10 1987-07-10 Injektionsloesung von cephalosporinen. Expired - Fee Related DE3770355D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61160746A JP2690009B2 (ja) 1986-07-10 1986-07-10 セフアロスポリン注射剤

Publications (1)

Publication Number Publication Date
DE3770355D1 true DE3770355D1 (de) 1991-07-04

Family

ID=15721560

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787109995T Expired - Fee Related DE3770355D1 (de) 1986-07-10 1987-07-10 Injektionsloesung von cephalosporinen.

Country Status (8)

Country Link
US (1) US4822785A (de)
EP (1) EP0253329B1 (de)
JP (1) JP2690009B2 (de)
AT (1) ATE63814T1 (de)
CA (1) CA1293445C (de)
DE (1) DE3770355D1 (de)
ES (1) ES2039215T3 (de)
GR (1) GR3002026T3 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5373000A (en) * 1985-12-26 1994-12-13 Eisai Co., Ltd. 7Beta-(thiadiazolyl)-2-iminoacetamido-3cephem compounds
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
CA2026516C (en) * 1989-09-30 1998-02-17 Yasuo Ishibashi Injectable preparations containing cephalosporin medicament
ITMI20021040A1 (it) * 2002-05-16 2003-11-17 Novuspharma Spa Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale
AU2003241675A1 (en) * 2002-06-21 2004-01-06 Shionogi And Co., Ltd. Medicinal cephem compound composition for injection
EP1656930A1 (de) * 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilisierte gefriergetrocknete Formulierung für Cephalosporinderivate
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
MX2020004205A (es) * 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
KR101935186B1 (ko) 2014-09-04 2019-01-03 시오노기세야쿠 가부시키가이샤 카테콜기를 갖는 세팔로스포린류를 함유하는 제제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2760484C2 (de) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
IL77458A (en) * 1985-01-14 1990-07-26 Eisai Co Ltd Cephem derivatives,their production and antibacterial compositions containing them and certain novel intermediates therefor

Also Published As

Publication number Publication date
EP0253329A3 (en) 1989-07-26
ATE63814T1 (de) 1991-06-15
EP0253329A2 (de) 1988-01-20
JP2690009B2 (ja) 1997-12-10
CA1293445C (en) 1991-12-24
GR3002026T3 (en) 1992-12-30
ES2039215T3 (es) 1993-09-16
US4822785A (en) 1989-04-18
JPS6317827A (ja) 1988-01-25
EP0253329B1 (de) 1991-05-29

Similar Documents

Publication Publication Date Title
ATE118671T1 (de) Salze geringer flüchtigkeit.
DE3770355D1 (de) Injektionsloesung von cephalosporinen.
EP0171887A3 (en) Anti-diabetic compounds
IT1173617B (it) Robot dotato di sensore di prossimita' magnetico
DK413785A (da) Ekspektorationsmiddel
GB8617482D0 (en) Pharmaceutical composition
ZA879615B (en) Quinoline compound
DK169984A (da) Pyrimidinderivater
MX9203125A (es) Compuestos con actividad similar a la insulina, antidiabeticos.
FI860197A0 (fi) Pyridopyrimidiner, flera foerfaranden foer deras framstaellning samt deras anvaendning som laekemedel.
DE58908428D1 (de) Sekretormutante von Escherichia coli.
PH20699A (en) Salts of 2-keto-2h-1,2-benzisothiazole 1,1-dioxide as microbicides
FI860426A (fi) Primycinkomponenter samt foerfarande foer avskiljning av antibiotkomplex.
SE8104771L (sv) Cefalosporinderivat
ATE31295T1 (de) Benzoylharnstoffderivate.
ZA861266B (en) 4,5-disubstituted 1,3-thiazol-2-yloxyacetamides
ES2055708T3 (es) Peptidos.
DE3751626D1 (de) Stabilisierung von Polyphenylenethern mit makrocyclischen Polyalkylpiperidinverbindungen.
ES8100299A1 (es) Un procedimiento para preparar un semi-acido-sal cristalino de un derivado de cefalosporina
FI870623A0 (fi) Salt av ett substituerat morfolin och fluorborsyra samt traeskyddsmedel.
SE8601963L (sv) O-sulfaterade beta-laktamhydroxamsyror
FI904347A0 (fi) Nya foereningar.
JPS6110461B2 (de)
FI873483A (fi) Oxiranpseudooligosackarider, foerfarande foer deras framstaellning, deras anvaendning och farmaceutiska preparat.
DE3668597D1 (de) Ruderdolle.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee